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Background
Allergic Rhinitis (AR) is a worldwide spread illness hav-
ing an important impact on social life, sleep quality,
school, and work productivity and huge costs. Patient
preference is becoming an important aspect in medical
care. ISMAR was designed as the first-over global survey
to identify differences in attitudes and preference in
patients and physicians about AR. ISMAR 2 is the second
phase.
Methods
ISMAR is an international, multicenter, non-interven-
tional, cross-sectional study in adults and children (≥ 6
years) with physician-diagnosed AR of at least 1 year of
duration conducted in Algeria, Egypt, United Arab Emi-
rates, Qatar, Kuwait, India, Islamic Republic of Iran,
Pakistan, and Saudi Arabia.
Physicians (GPs/Family doctors/internists, pediatri-
cians, allergists/pulmonologists, and ENT) working in
public and private sectors or both were selected from
master lists of physicians attending AR patients and
invited to participate in the study. They answered to the
Investigator’s Questionnaire (guidelines awareness, rele-
vant AR symptoms, and preference for prescribing med-
ication among others) and recruited consecutive patients
to whom the ISMAR questionnaire was administered.
Data collection was performed during a single visit. A
patient’s questionnaire and a Case Record Form were
also filled in. Statistical analysis was descriptive. Herein
we are showing the physician’s view.
Results
One hundred and seventy eight physicians participated.
They were aware about ARIA (82.6%) and GINA
(76.4%) and followed them to classify patients severity
(83.7%) and for choosing the treatment accordingly
(82.0%). Key symptoms to diagnose AR were congestion
(85.4%), sneezing (93.3%), and anterior watery rhinor-
rhea (89.3%). SQ and AR severity were assessed mainly
by clinical history (93.8% and 98.7 %). The most com-
monly tests were serum total IgE (52.8%), eosinophilia
(50.0%), x-rays (48.9%), CT scan (44.4%), and allergen
skin tests (39.3%). The main reasons to prescribe medi-
cation were symptom severity/frequency (98.3 %), drug
efficacy (80.3% %) and safety (78.7 %). Other less rele-
vant reasons were personal experience (60.7 %), route of
administration (55.1%), cost (52.8%), and frequency of
doses (48.9%). The preferred medications were oral anti-
H1 antihistamines (Oa-H1: 68.5%) and intranasal corti-
costeroids (ICS: 64.0 %) [5 in a 0–5 scale].
Conclusions
Guidelines are well known and useful to physicians.
Clinical history was the main instrument to evaluate
patient’s SQ, classification and severity of AR, and
choice of treatment. Allergen skin tests were not com-
monly performed. Oa-H1 and ICS were the most widely
recommended treatment for AR and were considered
effective and safe.1Research Centre in Respiratory Medicine, Argentina
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